Clinical Management Recommendations for Surveillance and Risk-Reduction Strategies for Hereditary Breast and Ovarian Cancer Among Individuals Carrying a Deleterious BRCA1 or BRCA2 Mutation
科研成果: 期刊稿件 › 文章 › 同行评审
39
引用
(Scopus)